Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Lucia CarboniEnrico Domenici

Abstract

Chronic administration of antidepressants is required for their efficacy, suggesting the involvement of long-term modifications. As the impact of antidepressant treatment on the brain molecular machinery is not completely understood, we performed a proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine, with an NK1 receptor antagonist, GR205171, and a CRF receptor 1 antagonist, DMP696. After 2D electrophoresis, protein expression levels were compared with both univariate and multivariate statistical analyses and identified by mass spectrometry. All treatments modified levels of actin isoforms, whereas both fluoxetine and GR205171 reduced synapsin II. Fluoxetine treatment increased ERK2 and NP25 and decreased vacuolar ATP synthase. After GR205171 treatment, protein disulphide isomerase A was reduced; dynamin 1 and aldose reductase increased. DMP696 modulated DRP2, pyruvate kinase, LDH and ATP synthase. Although each compound induced a specific pattern of protein modulation, data suggest that antidepressants share the ability of modulating neural plasticity.

References

Mar 1, 1990·Trends in Neurosciences·P R MaycoxR Jahn
Mar 1, 1994·Brain Research. Molecular Brain Research·W Z RenC C Liew
Apr 24, 1997·Nature·W C DrevetsM E Raichle
Oct 27, 1998·Biological Psychiatry·E J Nestler
Apr 23, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·S HilfikerP Greengard
Apr 30, 1999·BMJ : British Medical Journal·O Spigset, B Mårtensson
Oct 29, 2000·Science·A Matus
Apr 3, 2001·The British Journal of Psychiatry : the Journal of Mental Science·I C Reid, C A Stewart
Aug 16, 2002·Bipolar Disorders·Maurizio PopoliGiorgio Racagni
Aug 16, 2002·Bipolar Disorders·Carrol D'Sa, Ronald S Duman
Oct 31, 2002·Nature Neuroscience·Charles B Nemeroff, Michael J Owens
Dec 24, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Haiyun XuXin-Min Li
Dec 31, 2002·The American Journal of Psychiatry·Joel A PosenerJohn G Csernansky
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·J Kehne, S De Lombaert
Nov 15, 2003·Current Biology : CB·Malavika Raman, Melanie H Cobb
Dec 11, 2003·Journal of Neural Transmission·N DriguesM B H Youdim
Feb 21, 2004·Nature Reviews. Neuroscience·Gareth M Thomas, Richard L Huganir
Mar 17, 2004·Current Opinion in Pharmacology·Eero Castrén
Mar 26, 2004·Neuroscience Research·Kenji MoriNoboru Sakai
Apr 14, 2004·Current Drug Targets. CNS and Neurological Disorders·Albert Adell
Apr 14, 2004·The European Journal of Neuroscience·Emmanuel ValjentJocelyne Caboche
May 11, 2004·Mass Spectrometry Reviews·Michael Fountoulakis
May 13, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ettore TiraboschiMaurizio Popoli
Jun 15, 2004·Current Opinion in Neurobiology·J David Sweatt
Aug 18, 2004·Trends in Molecular Medicine·Marianne B Müller, Wolfgang Wurst
Aug 19, 2004·The International Journal of Neuropsychopharmacology·Miklós PalotásJános Kálmán

❮ Previous
Next ❯

Citations

Mar 9, 2011·Biomedical Research·Yoshiaki Tsuboko, Atsuhiro Sakamoto
Dec 3, 2014·Brain Research·Sinead M O'DonovanDeclan M McLoughlin
Dec 21, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Chiara PiubelliLucia Carboni
Dec 18, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Eva M SzegoKatalin A Kékesi
Dec 20, 2007·Journal of Neurochemistry·Stephen W HunsuckerDavid Patterson
Feb 1, 2011·Proteomics. Clinical Applications·Michaela D FiliouDaniel Martins-de-Souza
Feb 26, 2010·Journal of Neurochemistry·Sylwia Kedracka-KrokMarta Dziedzicka-Wasylewska
Nov 10, 2015·Proteomics. Clinical Applications·Lucia Carboni, Enrico Domenici
Dec 19, 2014·The International Journal of Neuropsychopharmacology·Alessandra MalleiMaurizio Popoli
Jun 9, 2016·Neuroscience·Roberto Federico VillaFabio Tascedda
Feb 10, 2010·Journal of Psychopharmacology·Regina TaurinesJohannes Thome
Apr 7, 2009·Journal of Psychopharmacology·P C McHughM A Kennedy
Jun 20, 2008·Journal of Psychopharmacology·K PenningtonD R Cotter
Sep 18, 2007·Journal of Neuroscience Research·Patrick C McHughMartin A Kennedy
Nov 1, 2007·Proteomics. Clinical Applications·Ming D Li, Ju Wang
Aug 21, 2009·Nature Reviews. Neuroscience·Alex Bayés, Seth G N Grant
Oct 30, 2020·Frontiers in Cell and Developmental Biology·Jingwen LiuYan Wang
Jul 2, 2019·Trends in Biochemical Sciences·Lei-Miao YinYong-Qing Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

ATP Synthases

ATP synthases are enzymes located in the inner mitochondrial membrane that catalyze the synthesis of ATP during cellular respiration. Discover the latest research on ATP synthases here.